COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States
Amy DeGroff, Jacqueline W. Miller, Krishna P. Sharma, Jingjing Sun, William Helsel, William Kammerer, Tanner Rockwell, Amanda Sheu, Stephanie Melillo, Justin Uhd, Kristy Kenney, Faye L. Wong, Mona Saraiya, Lisa C. Richardson
Topics & Concepts
MedicineCervical cancerBreast cancerGynecologyBreast cancer screeningCancer screeningPublic healthObstetricsEthnic groupPandemicDemographyRuralityPacific islandersHealth careFamily medicineHealth equityCancerMammographyRural areaInternal medicineEnvironmental healthCoronavirus disease 2019 (COVID-19)DiseasePopulationNursingPathologyInfectious disease (medical specialty)AnthropologySociologyEconomicsEconomic growthGlobal Cancer Incidence and ScreeningCervical Cancer and HPV ResearchCOVID-19 and healthcare impacts